Jodi Warman Chardon

Jodi Warman Chardon

MD, PhD FRCPC (Neurology)

Associate Scientist, Neuroscience

Ottawa Hospital Research Institute

Associate Scientist, Clinical Epidemiology

Ottawa Hospital Research Institute

Clinician Scientist, Neurology

The Ottawa Hospital

Associate Professor, Faculty of Medicine

University of Ottawa

Co-Director, Centre for Neuromuscular Disease

Faculty of Medicine

Contact

613-798-5555 ext. 16221

Administrative Assistant Sabrynna Provost 613-798-5555 ext. 16221 saprovost@toh.ca

Bio

Dr Jodi Warman-Chardon is a Clinician-Scientist in the Department of Medicine at the Ottawa Hospital, Ottawa Hospital Research Institute (OHRI) in Neurosciences and Clinical Epidemiology and Department of Genetics at the Children’s Hospital of Eastern Ontario/CHEO RI. She is a Tier 2 Clinical Research Chair in Diagnosis and Discovery Pipeline for Patients with Genetic Neuromuscular Disease at the University of Ottawa. Dr. Warman received her MD/Neurology residency at the University of Ottawa and MSc from Queen’s University, and PhD from McGill University. She completed research and clinical fellowships in neuromuscular disorders from McGill University and neurogenetics at the University of Ottawa and is certified by the Canadian Society of Clinical Neurophysiologists (EMG). She led the strategic development and is now Director of the Ottawa Hospital Neuromuscular Centre, a diagnostic clinical research centre for patients with NMD. She was also co-director of the uOttawa Centre for Neuromuscular Disease, which unites over 60 clinical and basic NMD researchers. Dr. Warman-Chardon's research program and clinical practice focuses on the diagnosis and the clinical characterization of patients with rare or novel inherited neuromuscular disease by Magnetic Resonance Imaging (MRI), novel biomarker discovery and genomics diagnostics.

Research Goals and Interests

Dr. Warman-Chardon's primary research interest focuses on identifying the molecular basis and the clinical characterization of rare disease, utilizing imaging, novel genetic techniques to drive gene identification and the phenotypic expansion of many rare neuromuscular disorders. She and her colleagues have successfully identified several novel genes, and are continuing to assess evolving imaging, genomics and serum biomarkers as clinical tools to help patients living with neuromuscular disease.


News


Related Research at The Ottawa Hospital